Bafilomycin-like metabolite from a novel micromonospora species
CA 2489041 C · Owner: Albany Molecular Research, Inc. · Inventors: Wouters, Walter Boudewijn Leopold; Janicot, Michel Marie Francois; Mocek, Ursula Maria
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a compound of formula (I) and pharmaceutically acceptable salts thereof. Processes for the isolating of this bafilomycin metabolite from a novel Micromonospora species pharmaceutical compositions , containing this metabolite and methods of treatment using said metabolite are also described.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 30, 2003 and granted June 5, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 30, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 30, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.